Talecris Biotherapeutics
Clinical Studies
Print This Page E-mail This Page
Talecris Clinical Studies
Clinical Study Results

Talecris Clinical Study Results

Please note:  Analyses and references made in any study summary were appropriate when written, but circumstances may have changed.

Select a clinical study to view:

  Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
 
  Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients
 
  Rapid Infusion of Immune Globulin Intravenous (IGIV) In Patients With ITP
 
  Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)
 
  Deposition of Inhaled Prolastin in Cystic Fibrosis Patients (CF2)
 
  Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ICE Study)
 
  Tetanus Immunization In Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
 

 

 
Talecris Biotherapeutics
Site Map    General Conditions of Use    Privacy Statement   
© 2008 Talecris Biotherapeutics